Controversies in Primary Care

OSUWexnerbloglogo2014 Controversies in Primary Care is the topic of our latest webcast. What Galileo taught was that sometimes the most widely accepted dogma isn’t always right. Controversies still exist in medicine and today, we’re going to take an in depth look at one of the more pressing controversies in primary care medicine, whether and how patients with pre-diabetes should be treated. In the studio, with our Moderator Dr. Jim Allen, is Assistant Professor of Internal Medicine from the Division of General Internal Medicine at The Ohio State University Wexner Medical Center, Dr. Kevin Goist.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the importance of recognizing pre-diabetes; and DISCUSS the potential treatments for pre-diabetes

You’ll also learn about the following:

  • The evolving concept of pre-diabetes
  • Risk factors for developing diabetes
  • Preventing diabetes and pre-diabetes
  • Timing of screening for pre-diabetes
  • Whether children should be screened
  • When to discontinue treatment for pre-diabetes
  • Cost of treatment
  • Pre-hypertension and pre-hyperlipidemia

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

New Developments in Lung Cancer Treatment

OSUWexnerbloglogo2014 New Developments in Lung Cancer Treatment. Lung cancer now accounts for 14% of all cancers but it is the most common cause of cancer death, In fact, more people die each year from lung cancer than from colon cancer, breast cancer, and prostate cancer combined. The 5-year survival rate of lung cancer is only 18% but the good news is that we have a lot of new medications that are giving patients with lung cancer longer and better lives. On our CME webcast, to discuss new treatments in lung cancer, are two of Ohio State’s experts in the management of lung cancer. Joining our moderator, Dr. Jim Allen, we have Dr. Greg Otterson who is a Professor of Internal Medicine from the Division of Medical Oncology and Dr. Erin Bertino, an Assistant Professor of Internal Medicine, also from the Division of Medical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: GAIN an understanding of the importance of genomic testing in the initial workup of patients with lung cancer. EXPLAIN the evolving role of immune mediated therapy in lung cancer; RECOGNIZE the clinical benefit for patients receiving targeted therapies; and DESCRIBE the patient characteristics commonly associated with actionable mutations in lung cancer.

You’ll also learn about the following:

  • The most fatal of all common cancers
  • Evolving chemotherapy treatment of lung cancer
  • Sub-classifying adenocarcinomas
  • Squamous cell lung cancer treatment
  • Large cell undifferentiated lung cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get Educated on the Evolving Role of Pharmacists

OSUWexnerbloglogo2014Get Educated on the Evolving Role of Pharmacists.  The role of the pharmacist has evolved into much more of a patient management discipline and not just drug mixing and dispensing.  In fact, most physicians don’t even know what today’s pharmacists can do and how they can help improve health outcomes in our patients.  In the studio with our moderator, Dr. Jim Allen, to tell us about the expanding role of the pharmacist are PharmDs from the Ohio State University.  We have Melissa Snider, who is an Assistant Professor in the Department of Pharmacy and is the assistant director of pharmacy at the Wexner Medical Center.  Along with her, we have Trisha Jordan who is also an Assistant Professor of Pharmacy and the associate director of pharmacy at the Wexner Medical Center.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DEMONSTRATE why and how healthcare is changing; and RECOGNIZE how pharmacists can participate in associated outcomes.

You’ll also learn about the following:

  • Training for pharmacists in the United States
  • State-specific pharmacy scope of practice
  • Medicare reimbursement for pharmacist services
  • Innovative use of pharmacists at the OSU Wexner Medical Center

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.